查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2093216

數位病患監測設備市場－全球市場預測（2026-2032年）

Digital Patient Monitoring Devices Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，數位病患監測設備市場將成長至 4,261.7 億美元，複合年成長率為 16.29%。

主要市場統計數據
基準年 2025 1481.7億美元
預計年份：2026年 1716.2億美元
預測年份 2032 4261.7億美元
複合年成長率 (%) 16.29%

隨著醫療保健系統應對慢性病盛行率上升、人口老化、人員短缺以及院外照護需求不斷成長等問題，數位化病患監測設備已成為現代醫療保健服務的重要組成部分。這些設備包括穿戴式監視器、連網血壓監測儀、脈動式血氧監測儀系統、血糖監測系統、心電圖貼片、智慧體溫計、呼吸監測儀以及多參數遠端患者監護平台。這些設備的價值在於能夠持續或近乎即時地收集數據，及早發現臨床惡化，增強患者用藥依從性，並改善醫院、門診、居家醫療和長期護理機構之間的護理協調。

遠端保健的擴展、部分醫療系統針對遠端患者監護的保險報銷途徑的建立，以及患者對連線健診工具日益成長的熟悉度，都在推動這些設備的普及。公共衛生機構持續強調心血管疾病、糖尿病、慢性呼吸系統疾病和高血壓等非傳染性疾病負擔的日益加重，這進一步凸顯了長期監測的臨床需求。監管機構也不斷完善關於醫療設備的軟體、網路安全、互通性和臨床有效性的指導方針，而實證實踐則是商業化的核心。對於相關人員而言，這一領域不再僅僅由設備硬體定義，而是日益受到一個整合生態系統的影響，該生態系統融合了感測器、雲端平台、分析功能、與電子健康記錄的整合、臨床工作流程以及病人參與功能。

數位監測領域的變革性變化

數位病患監測領域正從間歇性監測轉向持續性、預防性和個人化照護。醫院和醫療保健系統正在利用遠端患者監護設備來支持早期出院、減少不必要的再入院，並擴大對心血管疾病、糖尿病、呼吸系統疾病、孕產婦健康風險以及需要急性後期康復患者的專科管理。同時，隨著保險公司和醫療保健提供者努力在臨床認為合適的情況下，在傳統醫療機構之外管理危重患者，居家照護模式也在不斷發展。

人工智慧（AI）的累積影響

人工智慧 (AI) 透過將原始生物特徵資料流轉化為可操作的洞察，正在拓展數位病患監測設備的臨床和營運影響力。 AI 演算法能夠幫助臨床醫生識別需要及時介入的患者，並透過異常檢測、風險分層、趨勢分析、藥物依從性追蹤和警報優先排序等功能，減輕警報疲勞。在慢性病管理中，機器學習模型正被擴大應用於血糖值模式、心率節律數據、血壓變異性、睡眠指標、呼吸訊號以​​及病情惡化的多參數指標等方面的分析。

主要區域洞察：亞太地區、歐洲、北美、拉丁美洲、非洲、中東

亞太地區正迅速崛起為數位病患監測設備市場，這得益於其龐大的患者群體、數位醫療的快速普及、行動連線的不斷擴展以及政府主導的醫療數位化。互聯監護技術正在亞太各國廣泛應用，以應對專科醫生短缺、支持慢性病管理以及將醫療服務拓展至社區和家庭環境。日本、韓國、澳洲、中國和印度尤其重要，因為它們擁有先進的數位基礎設施、人口老化、非傳染性疾病負擔日益加重以及對遠端醫療醫療的接受度不斷提高。

主要組織概況：北約、七國集團、金磚國家、歐盟、東協、海灣合作理事會

儘管北約成員國並非一個單一的醫療健康集團，但其中許多國家在數位化醫療應用方面處於領先地位，因此，網路安全、供應鏈韌性、互通性以及關鍵醫療基礎設施的保護對於互聯醫療設備而言日益重要。七國集團（G7）國家的特點是醫療健康體系先進、人口老化、慢性病負擔沉重、法律規範體係成熟，並且在整合受監管的數位療法和遠端患者監護擁有穩固的路徑。在這些經濟體中，臨床證據、安全的人工智慧部署、健康資料管治以及安全的互聯醫療基礎設施越來越受到重視。

各國主要數位醫療市場的發展趨勢

在中國，受醫院數位化、大規模連線健診醫療生態系統以及老齡化都市區對慢性病管理的強勁需求等因素推動，數位化病患監測正在迅速發展。美國是全球數位化病患監測設備部署的領導者，其遠端患者監護的保險報銷政策、廣泛的慢性病管理計畫以及將虛擬醫療與醫療服務提供者的運作緊密結合，都為這一發展提供了有力支持。日本則專注於老年護理、家庭監護以及高品質、合規的技術。同時，印度的市場機會主要得益於行動連線、不斷完善的數位公共衛生基礎設施以及將醫療服務擴展到服務不足人群的需求，但價格可負擔性和與臨床醫生工作流程的整合仍然至關重要。

為行業領導者提供的實用建議

產業領導者應優先考慮經臨床檢驗、能夠在醫療照護路徑中展現可衡量價值的數位病患監測設備，而不是將遠距監護視為獨立的技術。成功的策略是將設備功能與特定應用情境結合，例如心臟衰竭監測、高血壓管理、糖尿病護理、慢性阻塞性肺病(COPD)後續觀察、孕產婦監護、家庭醫院計畫、虛擬病房和術後復健。

調查方法

本執行摘要採用以二手資料研究主導的方法編寫，重點關注與數位病患監測設備相關的、檢驗的、公開可用的資訊來源。研究途徑考慮了監管指南、衛生政策文件、數位健康框架、臨床實踐趨勢、保險報銷更新、公共衛生數據、醫療設備軟體標準、網路安全指南以及關於遠端患者監護應用的同行評審證據。

結論

數位病患監測設備正在透過實現持續的態勢感知、早期療育和更加分散的護理模式，變革醫療保健產業。它們的作用正從簡單的生物特徵數據收集擴展到整合臨床決策支援、病人參與和人群健康管理。成長最顯著的領域是那些經過臨床檢驗、互通性、安全、可報銷並融入醫療服務提供者和患者實際工作流程的連網設備。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：數位病患監測設備市場：依產品類型分類

  • 嵌入式
    • 植入式心臟監測器
    • 神經刺激設備
  • 可攜式的
    • 血糖儀
    • 心電圖監測
  • 穿戴式裝置
    • 修補
    • 智慧型手錶
    • 腕帶

第8章：數位病患監測設備市場：依技術分類

  • Bluetooth
  • 細胞
  • RFID
  • Wi-Fi

第9章：數位病患監測設備市場：依連接類型分類

  • 即時監控
    • 持續監測
    • 間歇性監測
  • 存轉

第10章：數位病患監測設備市場：依應用領域分類

  • 心臟監測
    • 攜帶式心電圖
    • 連續型心電圖監測
    • 遙測
  • 糖尿病監測
    • 持續血糖監測
    • 血糖自我監測
  • 跌倒偵測
  • 神經系統監測
  • 呼吸監測
  • 生命徵象監測

第11章：數位病患監測設備市場：依最終用戶分類

  • 門診手術中心
  • 家庭醫療保健
  • 醫院和診所
    • 心臟科病房
    • 糖尿病診所

第12章：數位病患監測設備市場：依部署模式分類

  • 基於雲端的
  • 現場

第13章：數位病患監測設備市場：依通路分類

  • 直銷
  • 銷售代理
  • 線上銷售
  • 零售藥房

第14章：數位病患監測設備市場：按地區分類

  • 亞太地區
  • 歐洲
  • 北美洲
  • 拉丁美洲
  • 非洲
  • 中東

第15章：數位病患監測設備市場：依組別分類

  • NATO
  • G7
  • BRICS
  • EU
  • ASEAN
  • GCC

第16章 數位病患監測設備市場：按國家/地區分類

  • 中國
  • 美國
  • 日本
  • 印度
  • 德國
  • 英國
  • 澳洲
  • 法國
  • 韓國
  • 義大利
  • 加拿大
  • 俄羅斯
  • 巴西
  • 墨西哥
  • 西班牙

第17章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第18章：公司簡介

  • Abbott Laboratories
  • Apple Inc.
  • AT&T Inc.
  • athenahealth, Inc.
  • Baxter International Inc.
  • BioTelemetry, Inc.
  • Biotronik SE & Co. KG
  • Dragerwerk AG & Co. KGaA
  • F. Hoffmann-La Roche Ltd
  • Fitbit, Inc.
  • Garmin Ltd.
  • GE Healthcare Technologies Inc.
  • Koninklijke Philips NV
  • Medtronic plc
  • Mindray Bio-Medical Electronics Co., Ltd.
  • Natus Medical Incorporated
  • OMRON Corporation
  • ResMed Inc.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthineers AG
  • Siren Care, Inc.
  • Smiths Medical, Inc.
  • VitalConnect, Inc.
Product Code: MRR-B973EDD5EA1B

The Digital Patient Monitoring Devices Market is projected to grow by USD 426.17 billion at a CAGR of 16.29% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 148.17 billion
Estimated Year [2026] USD 171.62 billion
Forecast Year [2032] USD 426.17 billion
CAGR (%) 16.29%

Digital patient monitoring devices have become a critical layer of modern healthcare delivery as health systems respond to rising chronic disease prevalence, aging populations, workforce constraints, and growing demand for care beyond hospital walls. These devices include wearable monitors, connected blood pressure cuffs, pulse oximeters, glucose monitoring systems, ECG patches, smart thermometers, respiratory monitors, and multi-parameter remote patient monitoring platforms. Their value lies in continuous or near-real-time data capture, earlier detection of clinical deterioration, stronger adherence support, and improved care coordination across hospitals, ambulatory settings, home healthcare, and long-term care environments.

Adoption is being reinforced by the expansion of telehealth, reimbursement pathways for remote patient monitoring in several healthcare systems, and increasing patient comfort with connected health tools. Public health agencies continue to highlight the growing burden of noncommunicable diseases, including cardiovascular disease, diabetes, chronic respiratory disease, and hypertension, which strengthens the clinical need for longitudinal monitoring. Regulatory agencies are also refining guidance for software as a medical device, cybersecurity, interoperability, and clinical validation, making evidence generation central to commercialization. For stakeholders, the sector is no longer defined only by device hardware; it is increasingly shaped by integrated ecosystems combining sensors, cloud platforms, analytics, electronic health record connectivity, clinical workflows, and patient engagement capabilities.

Transformative Shifts in the Digital Monitoring Landscape

The digital patient monitoring landscape is shifting from episodic measurement toward continuous, preventive, and personalized care. Hospitals and health systems are using remote patient monitoring devices to support earlier discharge, reduce avoidable readmissions, and extend specialist oversight to patients managing cardiovascular disease, diabetes, respiratory disorders, maternal health risks, and post-acute recovery needs. At the same time, home-based care models are expanding as payers and providers seek to manage high-acuity patients outside traditional facilities where clinically appropriate.

Interoperability has become a defining competitive requirement. Devices that generate clinically useful data must increasingly integrate with electronic health records, care management platforms, pharmacy systems, and population health tools. Cybersecurity and data privacy are also moving from technical afterthoughts to core procurement criteria, particularly as connected medical devices become part of critical healthcare infrastructure. Another major shift is the transition from patient-owned wellness-style devices to clinically validated, regulated monitoring solutions capable of supporting diagnosis, triage, treatment adjustment, and longitudinal disease management.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is amplifying the clinical and operational impact of digital patient monitoring devices by transforming raw biometric streams into actionable insights. AI-enabled algorithms can support anomaly detection, risk stratification, trend analysis, adherence tracking, and alert prioritization, helping clinicians identify patients who require timely intervention while reducing alarm fatigue. In chronic disease management, machine learning models are increasingly applied to glucose patterns, cardiac rhythm data, blood pressure variability, sleep metrics, respiratory signals, and multi-parameter deterioration indicators.

The cumulative impact of AI is most visible where monitoring programs are linked with clinical workflows and validated decision support. AI can help segment patients by acuity, personalize thresholds, detect subtle deviations from baseline, and support predictive care pathways. However, adoption depends on transparent validation, bias mitigation, explainability, regulatory compliance, and clinical accountability. Healthcare organizations are placing greater emphasis on algorithms trained on representative datasets, audited for performance drift, and deployed with human oversight. As a result, AI is becoming a strategic enabler of scalable remote patient monitoring rather than a standalone feature.

Key Regional Insights: Asia-Pacific, Europe, North America, Latin America, Africa, and Middle East

Asia-Pacific is emerging as a highly dynamic region for digital patient monitoring devices due to large patient populations, rapid digital health adoption, expanding mobile connectivity, and government-led healthcare digitization. Countries across the region are using connected monitoring to address gaps in specialist access, support chronic disease management, and extend care into community and home settings. Japan, South Korea, Australia, China, and India are particularly important due to their advanced digital infrastructure, aging demographics, rising noncommunicable disease burden, and increasing acceptance of telehealth-enabled care.

Europe is characterized by strong regulatory oversight, data protection requirements, cross-border digital health initiatives, and increasing emphasis on evidence-based adoption. Germany, France, the United Kingdom, Italy, and Spain are advancing remote patient monitoring through digital health reimbursement pathways, hospital modernization, virtual wards, and chronic care programs. North America remains one of the most mature environments for remote patient monitoring, supported by established reimbursement mechanisms, widespread electronic health record use, strong hospital digital transformation programs, and a high burden of chronic conditions such as diabetes, hypertension, cardiovascular disease, and chronic respiratory illness. The United States has seen especially strong integration of remote monitoring into value-based care, post-acute care, and chronic care management models, while Canada's public health system is advancing virtual care and remote monitoring to improve access across rural and underserved communities.

Latin America is advancing through telemedicine expansion, mobile-first healthcare access, and growing public-private initiatives to strengthen chronic disease monitoring. Brazil and Mexico are central to regional development due to their large healthcare systems and increasing investment in digital health infrastructure. Africa shows rising potential for digital patient monitoring through mobile health platforms, decentralized care models, and remote access solutions, although infrastructure variability, affordability, and workforce capacity remain key constraints. The Middle East is prioritizing digital health as part of national healthcare transformation strategies, particularly in Gulf economies where smart hospital programs, connected care infrastructure, and chronic disease prevention initiatives are expanding.

Across Asia-Pacific, Europe, North America, Latin America, Africa, and the Middle East, the strongest adoption patterns are associated with reimbursement clarity, regulatory trust, clinical validation, broadband and mobile connectivity, cybersecurity readiness, and integration into provider workflows.

Key Group Insights: NATO, G7, BRICS, European Union, ASEAN, and GCC

NATO countries, while not a healthcare bloc, include many advanced digital health adopters where cybersecurity, supply chain resilience, interoperability, and protection of critical healthcare infrastructure are increasingly important considerations for connected medical devices. The G7 group is defined by advanced healthcare systems, aging populations, high chronic disease burdens, mature regulatory oversight, and stronger pathways for regulated digital therapeutics and remote patient monitoring integration. These economies are placing growing emphasis on clinical evidence, safe AI deployment, health data governance, and secure connected care infrastructure.

BRICS countries represent diverse but influential environments for digital patient monitoring devices. China and India offer large-scale digital health deployment opportunities, Brazil is expanding connected care in public and private healthcare networks, Russia has emphasized telemedicine and digital health infrastructure, and South Africa supports digital tools for access improvement amid resource constraints. The European Union emphasizes regulatory harmonization, privacy protection, cybersecurity, and evidence-based deployment, with connected monitoring increasingly aligned with digital health records, cross-border health data frameworks, medical device regulations, and aging population strategies.

ASEAN countries are increasingly adopting digital patient monitoring devices as part of broader digital health and universal health coverage efforts. The region's mobile-first population, expanding telemedicine use, and need to improve access across islands, rural areas, and urban centers make remote monitoring relevant for chronic disease management, maternal health, and post-discharge care. However, procurement maturity, interoperability standards, and data governance differ significantly across member states, requiring localized market access strategies. The GCC is advancing connected patient monitoring through national health transformation agendas, smart city initiatives, and investment in digitally enabled hospitals. High prevalence of diabetes, cardiovascular conditions, and obesity-related complications supports demand for continuous monitoring and preventive care across Gulf health systems.

Key Country Insights Across Major Digital Health Markets

China is scaling digital patient monitoring through hospital digitization, large connected health ecosystems, and strong demand for chronic disease management among aging and urban populations. The United States is a leading adopter of digital patient monitoring devices due to reimbursement support for remote patient monitoring, widespread chronic disease management programs, and strong integration of virtual care into provider operations. Japan is focused on aging-related care, home monitoring, and high-quality regulated technologies, while India's opportunity is driven by mobile connectivity, expanding digital public health infrastructure, and the need to extend care to underserved populations, although affordability and clinician workflow integration remain essential.

Germany has become a key environment for regulated digital health adoption, supported by structured reimbursement approaches, strong medical technology standards, and robust data protection expectations. The United Kingdom is advancing remote monitoring through virtual wards, chronic disease programs, and digital-first care pathways. Australia is using remote monitoring to improve rural access, manage chronic disease, and support digitally enabled care models, while France is expanding remote monitoring through national digital health frameworks and disease-specific care programs. South Korea combines advanced broadband infrastructure, digital health innovation, and hospital technology adoption, making it a strong environment for connected monitoring solutions.

Italy and Spain are using connected patient monitoring to address aging populations, regional healthcare capacity pressures, and chronic condition management. Canada is using remote monitoring to improve access across geographically dispersed populations, particularly for chronic care, rural health, and post-acute follow-up. Russia has promoted telehealth and digital health infrastructure, though adoption conditions are shaped by regulatory, economic, and supply chain factors. Brazil's large public and private healthcare systems are encouraging connected care models for diabetes, hypertension, and cardiovascular conditions, while Mexico is expanding digital health adoption through growing telemedicine use and increasing demand for accessible chronic disease monitoring.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated digital patient monitoring devices that demonstrate measurable value in care pathways rather than positioning remote monitoring as a standalone technology purchase. Successful strategies should align device capabilities with specific use cases such as heart failure monitoring, hypertension management, diabetes care, chronic obstructive pulmonary disease follow-up, maternal monitoring, hospital-at-home programs, virtual wards, and post-surgical recovery.

Organizations should invest in interoperability, cybersecurity, and regulatory readiness from the earliest stages of product development and deployment. Integration with electronic health records, clinician dashboards, patient engagement tools, and escalation protocols is essential for adoption at scale. Leaders should also design monitoring programs that reduce clinician burden by using intelligent triage, configurable alert thresholds, and clear accountability models. Evidence generation should include clinical outcomes, workflow efficiency, patient adherence, health equity, and total cost-of-care indicators where applicable. For international expansion, companies and healthcare organizations should adapt to local reimbursement policies, data protection laws, infrastructure realities, language needs, and clinical practice patterns.

Research Methodology

This executive summary is developed using a secondary research-driven methodology focused on verified, publicly available, and evidence-based sources relevant to digital patient monitoring devices. The research approach considers regulatory guidance, healthcare policy documents, digital health frameworks, clinical practice trends, reimbursement updates, public health data, standards for medical device software, cybersecurity guidance, and peer-reviewed evidence on remote patient monitoring applications.

The analysis evaluates technology adoption across care settings, including hospitals, ambulatory care, home healthcare, long-term care, and telehealth-enabled programs. Regional, group, and country-level insights are interpreted through healthcare infrastructure maturity, digital health policy, chronic disease burden, demographic trends, reimbursement readiness, data privacy frameworks, cybersecurity expectations, and interoperability requirements. The methodology avoids speculative market sizing or forecasting and instead emphasizes validated industry drivers, adoption barriers, regulatory context, and strategic implications for stakeholders.

Conclusion

Digital patient monitoring devices are reshaping healthcare by enabling continuous insight, earlier intervention, and more distributed models of care. Their role is expanding from simple biometric capture to integrated clinical decision support, patient engagement, and population health management. The strongest momentum is occurring where connected devices are clinically validated, interoperable, secure, reimbursable, and embedded into practical workflows for providers and patients.

Artificial intelligence, home-based care, virtual wards, chronic disease programs, and value-based care models will continue to influence adoption patterns. However, sustainable success depends on evidence, trust, usability, cybersecurity, regulatory compliance, and equitable access. Healthcare leaders that treat digital patient monitoring as part of a connected care ecosystem rather than a device category alone will be better positioned to improve outcomes, optimize resources, and meet the growing demand for proactive, patient-centered healthcare.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Digital Patient Monitoring Devices Market, by Product Type

  • 7.1. Introduction
  • 7.2. Implantable
    • 7.2.1. Cardiac Implantable Monitor
    • 7.2.2. Neurostimulator
  • 7.3. Portable
    • 7.3.1. Glucometer
    • 7.3.2. Holter Monitor
  • 7.4. Wearable
    • 7.4.1. Patch
    • 7.4.2. Smartwatch
    • 7.4.3. Wristband

8. Digital Patient Monitoring Devices Market, by Technology

  • 8.1. Introduction
  • 8.2. Bluetooth
  • 8.3. Cellular
  • 8.4. RFID
  • 8.5. Wi-Fi

9. Digital Patient Monitoring Devices Market, by Connectivity Type

  • 9.1. Introduction
  • 9.2. Real-Time Monitoring
    • 9.2.1. Continuous Monitoring
    • 9.2.2. Intermittent Monitoring
  • 9.3. Store And Forward

10. Digital Patient Monitoring Devices Market, by Application

  • 10.1. Introduction
  • 10.2. Cardiac Monitoring
    • 10.2.1. Ambulatory Ecg
    • 10.2.2. Holter Monitoring
    • 10.2.3. Telemetry
  • 10.3. Diabetes Monitoring
    • 10.3.1. Continuous Glucose Monitoring
    • 10.3.2. Self Monitoring Of Blood Glucose
  • 10.4. Fall Detection
  • 10.5. Neurological Monitoring
  • 10.6. Respiratory Monitoring
  • 10.7. Vital Sign Monitoring

11. Digital Patient Monitoring Devices Market, by End User

  • 11.1. Introduction
  • 11.2. Ambulatory Surgical Centers
  • 11.3. Home Healthcare
  • 11.4. Hospitals And Clinics
    • 11.4.1. Cardiac Units
    • 11.4.2. Diabetes Clinics

12. Digital Patient Monitoring Devices Market, by Deployment Mode

  • 12.1. Introduction
  • 12.2. Cloud-Based
  • 12.3. On-Premise

13. Digital Patient Monitoring Devices Market, by Distribution Channel

  • 13.1. Introduction
  • 13.2. Direct Sales
  • 13.3. Distributors
  • 13.4. Online Sales
  • 13.5. Retail Pharmacies

14. Digital Patient Monitoring Devices Market, by Region

  • 14.1. Asia-Pacific
  • 14.2. Europe
  • 14.3. North America
  • 14.4. Latin America
  • 14.5. Africa
  • 14.6. Middle East

15. Digital Patient Monitoring Devices Market, by Group

  • 15.1. NATO
  • 15.2. G7
  • 15.3. BRICS
  • 15.4. European Union
  • 15.5. ASEAN
  • 15.6. GCC

16. Digital Patient Monitoring Devices Market, by Country

  • 16.1. China
  • 16.2. United States
  • 16.3. Japan
  • 16.4. India
  • 16.5. Germany
  • 16.6. United Kingdom
  • 16.7. Australia
  • 16.8. France
  • 16.9. South Korea
  • 16.10. Italy
  • 16.11. Canada
  • 16.12. Russia
  • 16.13. Brazil
  • 16.14. Mexico
  • 16.15. Spain

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2025
  • 17.2. FPNV Positioning Matrix, 2025
  • 17.3. Market Concentration Analysis, 2025
    • 17.3.1. Concentration Ratio (CR)
    • 17.3.2. Herfindahl Hirschman Index (HHI)
  • 17.4. Recent Developments & Impact Analysis, 2025
  • 17.5. Product Portfolio Analysis, 2025
  • 17.6. Benchmarking Analysis, 2025

18. Company Profiles

  • 18.1. Abbott Laboratories
  • 18.2. Apple Inc.
  • 18.3. AT&T Inc.
  • 18.4. athenahealth, Inc.
  • 18.5. Baxter International Inc.
  • 18.6. BioTelemetry, Inc.
  • 18.7. Biotronik SE & Co. KG
  • 18.8. Dragerwerk AG & Co. KGaA
  • 18.9. F. Hoffmann-La Roche Ltd
  • 18.10. Fitbit, Inc.
  • 18.11. Garmin Ltd.
  • 18.12. GE Healthcare Technologies Inc.
  • 18.13. Koninklijke Philips N.V.
  • 18.14. Medtronic plc
  • 18.15. Mindray Bio-Medical Electronics Co., Ltd.
  • 18.16. Natus Medical Incorporated
  • 18.17. OMRON Corporation
  • 18.18. ResMed Inc.
  • 18.19. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 18.20. Siemens Healthineers AG
  • 18.21. Siren Care, Inc.
  • 18.22. Smiths Medical, Inc.
  • 18.23. VitalConnect, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL DIGITAL PATIENT MONITORING DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL DIGITAL PATIENT MONITORING DEVICES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL DIGITAL PATIENT MONITORING DEVICES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL DIGITAL PATIENT MONITORING DEVICES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL DIGITAL PATIENT MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 27. GLOBAL DIGITAL PATIENT MONITORING DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL DIGITAL PATIENT MONITORING DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL IMPLANTABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL IMPLANTABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL IMPLANTABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CARDIAC IMPLANTABLE MONITOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CARDIAC IMPLANTABLE MONITOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CARDIAC IMPLANTABLE MONITOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NEUROSTIMULATOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NEUROSTIMULATOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NEUROSTIMULATOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PORTABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PORTABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PORTABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL GLUCOMETER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL GLUCOMETER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL GLUCOMETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HOLTER MONITOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HOLTER MONITOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HOLTER MONITOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL WEARABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL WEARABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL WEARABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PATCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PATCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PATCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SMARTWATCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SMARTWATCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SMARTWATCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL WRISTBAND MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL WRISTBAND MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL WRISTBAND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BLUETOOTH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BLUETOOTH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BLUETOOTH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CELLULAR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CELLULAR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CELLULAR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL RFID MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL RFID MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL RFID MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL WI-FI MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL WI-FI MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL WI-FI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL REAL-TIME MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL REAL-TIME MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL REAL-TIME MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CONTINUOUS MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CONTINUOUS MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CONTINUOUS MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL INTERMITTENT MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTERMITTENT MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL INTERMITTENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL STORE AND FORWARD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL STORE AND FORWARD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL STORE AND FORWARD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CARDIAC MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CARDIAC MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CARDIAC MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL AMBULATORY ECG MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL AMBULATORY ECG MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL AMBULATORY ECG MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL HOLTER MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL HOLTER MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL HOLTER MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL TELEMETRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL TELEMETRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL TELEMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL DIABETES MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL DIABETES MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL DIABETES MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CONTINUOUS GLUCOSE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SELF MONITORING OF BLOOD GLUCOSE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SELF MONITORING OF BLOOD GLUCOSE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SELF MONITORING OF BLOOD GLUCOSE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL FALL DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL FALL DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL FALL DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL NEUROLOGICAL MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL NEUROLOGICAL MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL NEUROLOGICAL MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL RESPIRATORY MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL RESPIRATORY MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL RESPIRATORY MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL VITAL SIGN MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL VITAL SIGN MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL VITAL SIGN MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL HOME HEALTHCARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL HOME HEALTHCARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL HOME HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL HOSPITALS AND CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL HOSPITALS AND CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL HOSPITALS AND CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL CARDIAC UNITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL CARDIAC UNITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL CARDIAC UNITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL DIABETES CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL DIABETES CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL DIABETES CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL CLOUD-BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL CLOUD-BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL CLOUD-BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL ON-PREMISE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL ON-PREMISE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ON-PREMISE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL DIRECT SALES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL DIRECT SALES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL DIRECT SALES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL DISTRIBUTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL DISTRIBUTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL DISTRIBUTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL ONLINE SALES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL ONLINE SALES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL ONLINE SALES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY IMPLANTABLE, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY REAL-TIME MONITORING, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY CARDIAC MONITORING, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY IMPLANTABLE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY REAL-TIME MONITORING, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY CARDIAC MONITORING, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY IMPLANTABLE, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY REAL-TIME MONITORING, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY CARDIAC MONITORING, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY IMPLANTABLE, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY REAL-TIME MONITORING, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY CARDIAC MONITORING, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY IMPLANTABLE, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY REAL-TIME MONITORING, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY CARDIAC MONITORING, 2018-2032 (USD MILLION)
  • TABLE 201. AFRICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING, 2018-2032 (USD MILLION)
  • TABLE 202. AFRICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY IMPLANTABLE, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY REAL-TIME MONITORING, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY CARDIAC MONITORING, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 221. GLOBAL DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 222. NATO DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 223. NATO DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. NATO DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY IMPLANTABLE, 2018-2032 (USD MILLION)
  • TABLE 225. NATO DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 226. NATO DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 227. NATO DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 228. NATO DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. NATO DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY REAL-TIME MONITORING, 2018-2032 (USD MILLION)
  • TABLE 230. NATO DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. NATO DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY CARDIAC MONITORING, 2018-2032 (USD MILLION)
  • TABLE 232. NATO DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING, 2018-2032 (USD MILLION)
  • TABLE 233. NATO DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. NATO DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 235. NATO DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 236. NATO DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 237. G7 DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 238. G7 DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. G7 DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY IMPLANTABLE, 2018-2032 (USD MILLION)
  • TABLE 240. G7 DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 241. G7 DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 242. G7 DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 243. G7 DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. G7 DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY REAL-TIME MONITORING, 2018-2032 (USD MILLION)
  • TABLE 245. G7 DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 246. G7 DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY CARDIAC MONITORING, 2018-2032 (USD MILLION)
  • TABLE 247. G7 DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING, 2018-2032 (USD MILLION)
  • TABLE 248. G7 DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 249. G7 DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 250. G7 DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 251. G7 DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. BRICS DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY IMPLANTABLE, 2018-2032 (USD MILLION)
  • TABLE 255. BRICS DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 256. BRICS DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 257. BRICS DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 258. BRICS DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. BRICS DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY REAL-TIME MONITORING, 2018-2032 (USD MILLION)
  • TABLE 260. BRICS DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 261. BRICS DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY CARDIAC MONITORING, 2018-2032 (USD MILLION)
  • TABLE 262. BRICS DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING, 2018-2032 (USD MILLION)
  • TABLE 263. BRICS DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 264. BRICS DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 265. BRICS DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 266. BRICS DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY IMPLANTABLE, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY REAL-TIME MONITORING, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY CARDIAC MONITORING, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPEAN UNION DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 282. ASEAN DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 283. ASEAN DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. ASEAN DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY IMPLANTABLE, 2018-2032 (USD MILLION)
  • TABLE 285. ASEAN DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 286. ASEAN DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 287. ASEAN DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 288. ASEAN DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 289. ASEAN DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY REAL-TIME MONITORING, 2018-2032 (USD MILLION)
  • TABLE 290. ASEAN DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 291. ASEAN DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY CARDIAC MONITORING, 2018-2032 (USD MILLION)
  • TABLE 292. ASEAN DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING, 2018-2032 (USD MILLION)
  • TABLE 293. ASEAN DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 294. ASEAN DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 295. ASEAN DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 296. ASEAN DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 297. GCC DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 298. GCC DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. GCC DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY IMPLANTABLE, 2018-2032 (USD MILLION)
  • TABLE 300. GCC DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 301. GCC DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 302. GCC DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 303. GCC DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 304. GCC DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY REAL-TIME MONITORING, 2018-2032 (USD MILLION)
  • TABLE 305. GCC DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 306. GCC DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY CARDIAC MONITORING, 2018-2032 (USD MILLION)
  • TABLE 307. GCC DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING, 2018-2032 (USD MILLION)
  • TABLE 308. GCC DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 309. GCC DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 310. GCC DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 311. GCC DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 312. GLOBAL DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 313. CHINA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 314. CHINA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 315. CHINA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY IMPLANTABLE, 2018-2032 (USD MILLION)
  • TABLE 316. CHINA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY PORTABLE, 2018-2032 (USD MILLION)
  • TABLE 317. CHINA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 318. CHINA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 319. CHINA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY CONNECTIVITY TYPE, 2018-2032 (USD MILLION)
  • TABLE 320. CHINA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY REAL-TIME MONITORING, 2018-2032 (USD MILLION)
  • TABLE 321. CHINA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 322. CHINA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY CARDIAC MONITORING, 2018-2032 (USD MILLION)
  • TABLE 323. CHINA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DIABETES MONITORING, 2018-2032 (USD MILLION)
  • TABLE 324. CHINA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 325. CHINA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2032 (USD MILLION)
  • TABLE 326. CHINA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 327. CHINA DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 328. UNITED STATES DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 329. UNITED STATES DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 330. UNITED STATES DIGITAL PATIENT MONITORING DEVICES MARKET SIZE, BY IMPLANTABLE,